PeterLabs Holdings Bhd (0171) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.107x

Based on the latest financial reports, PeterLabs Holdings Bhd (0171) has a cash flow conversion efficiency ratio of 0.107x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (RM8.43 Million ≈ $2.12 Million USD) by net assets (RM78.60 Million ≈ $19.73 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of PeterLabs Holdings Bhd for the company's overall valuation and market capitalisation.

PeterLabs Holdings Bhd - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how PeterLabs Holdings Bhd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

PeterLabs Holdings Bhd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of PeterLabs Holdings Bhd ranked by their cash flow conversion efficiency. Explore earnings quality score of PeterLabs Holdings Bhd to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Precipitate Gold Corp V:PRG	-0.093x
SPAR Group Inc NASDAQ:SGRP	-0.245x
Mannatech Incorporated NASDAQ:MTEX	0.347x
Grand Central Enterprises Bhd KLSE:5592	-0.003x
Niocan Inc V:NIO	-0.039x
Swvl Holdings Corp NASDAQ:SWVL	-0.177x
Telefield Inc KQ:091440	-0.062x
Domo Activos Socimi SA MC:DOMO	-0.014x

Annual Cash Flow Conversion Efficiency for PeterLabs Holdings Bhd (2015–2024)

The table below shows the annual cash flow conversion efficiency of PeterLabs Holdings Bhd from 2015 to 2024. View latest PeterLabs Holdings Bhd stock price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	RM76.94 Million ≈ $19.32 Million	RM12.39 Million ≈ $3.11 Million	0.161x	+125.23%
2023-12-31	RM75.76 Million ≈ $19.02 Million	RM5.42 Million ≈ $1.36 Million	0.071x	+4690.19%
2022-12-31	RM74.37 Million ≈ $18.67 Million	RM111.00K ≈ $27.87K	0.001x	+102.28%
2021-12-31	RM72.42 Million ≈ $18.18 Million	RM-4.74 Million ≈ $-1.19 Million	-0.065x	-139.00%
2020-12-31	RM58.36 Million ≈ $14.65 Million	RM9.78 Million ≈ $2.46 Million	0.168x	-16.76%
2019-12-31	RM52.47 Million ≈ $13.17 Million	RM10.57 Million ≈ $2.65 Million	0.201x	+519.97%
2018-12-31	RM48.26 Million ≈ $12.12 Million	RM1.57 Million ≈ $393.66K	0.032x	-18.48%
2017-12-31	RM45.74 Million ≈ $11.48 Million	RM1.82 Million ≈ $457.68K	0.040x	-81.09%
2016-12-31	RM39.43 Million ≈ $9.90 Million	RM8.31 Million ≈ $2.09 Million	0.211x	+876.31%
2015-12-31	RM38.99 Million ≈ $9.79 Million	RM-1.06 Million ≈ $-265.73K	-0.027x	--

About PeterLabs Holdings Bhd

KLSE:0171 Malaysia Drug Manufacturers - Specialty & Generic

Market Cap

$15.55 Million

RM61.92 Million MYR

Market Cap Rank

#25972 Global

#749 in Malaysia

Share Price

RM0.23

Change (1 day)

+2.27%

52-Week Range

RM0.20 - RM0.28

All Time High

RM0.45